A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers

Taste assessment of new formulation. Subjects will not ingest the drug.

Inclusion criteria

• Healthy male and/or female of non childbearing potential subjects between the ages of 18 and 75 years, inclusive.
• Subjects must be trained sensory panelists.
• An informed consent document signed and dated by the subject or a legally acceptable representative.
• Subjects who are willing and able to comply with scheduled visits, product evaluations, laboratory tests, and other study procedures.

Exclusion criteria

• A history of clinically significant hematological, renal, endocrine, pulmonary , glaucoma, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, allergic disease (excluding untreated, asymptomatic seasonal allergies at the time of product evaluation) as evaluated through a medical history.
• A history of hypersensitivity to any inactive ingredients employed in the formulation(s).
• Receiving treatment with an investigational drug within 28 days preceding any of the product evaluations for this study.
• Participation in a product taste evaluation (ie, 'sip and spit' type taste evaluation) involving an active pharmaceutical ingredient (API) within 5 half lives of that API.
• Unwilling or unable to comply with the Lifestyle guidelines described in this protocol.